Paper38112784
Primary central nervous system lymphoma.
de Koning ME and 5 others. J Neurol, 2024. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Primary central nervous system lymphoma. Papers, record 38112784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38112784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Central Nervous System Neoplasms | Major topic |
| Humans | |
| Lymphoma | |
| Lymphoma, Non-Hodgkin |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12525518 | Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12525518 | PubMed |
| 2 | 29054815 | Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. | Lancet Haematol | 2017 | https://conductscience.org/library/papers/29054815 | PubMed |
| 3 | 26367092 | Primary CNS lymphoma. | Curr Opin Ophthalmol | 2015 | https://conductscience.org/library/papers/26367092 | PubMed |
| 4 | 33611761 | MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma. | J Neurooncol | 2021 | https://conductscience.org/library/papers/33611761 | PubMed |
| 5 | 37468552 | Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748. | Leukemia | 2023 | https://conductscience.org/library/papers/37468552 | PubMed |
| 6 | 10659013 | Primary intracerebral malignant lymphoma: report of 248 cases. | J Neurosurg | 2000 | https://conductscience.org/library/papers/10659013 | PubMed |
| 7 | 18287338 | The utility of body FDG PET in staging primary central nervous system lymphoma. | Neuro Oncol | 2008 | https://conductscience.org/library/papers/18287338 | PubMed |
| 8 | 30628502 | Staging identifies non-CNS malignancies in a large cohort with newly diagnosed lymphomatous brain lesions. | Leuk Lymphoma | 2019 | https://conductscience.org/library/papers/30628502 | PubMed |
| 9 | 15925998 | Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. | J Neurooncol | 2005 | https://conductscience.org/library/papers/15925998 | PubMed |
| 10 | 35953526 | European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). | Neuro Oncol | 2023 | https://conductscience.org/library/papers/35953526 | PubMed |
| 11 | 17502548 | CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. | Neurology | 2007 | https://conductscience.org/library/papers/17502548 | PubMed |
| 12 | 21404136 | Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. | Ann Nucl Med | 2011 | https://conductscience.org/library/papers/21404136 | PubMed |
| 13 | 31832211 | Diagnosis of primary central nervous system lymphoma: a systematic review of the utility of CSF screening and the role of early brain biopsy. | Neurooncol Pract | 2019 | https://conductscience.org/library/papers/31832211 | PubMed |
| 14 | 34988333 | Subacute neurological deficits and respiratory insufficiency due to intrathecal methotrexate. | J Clin Transl Res | 2021 | https://conductscience.org/library/papers/34988333 | PubMed |
| 15 | 33615224 | Extent of radiological response does not reflect survival in primary central nervous system lymphoma. | Neurooncol Adv | 2021 | https://conductscience.org/library/papers/33615224 | PubMed |
| 16 | 30785830 | Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30785830 | PubMed |
| 17 | 23934519 | Neuroborreliosis and CNS lymphoma: what is the nexus? | Neurol Sci | 2013 | https://conductscience.org/library/papers/23934519 | PubMed |
| 18 | 30584023 | Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis. | Clin Lymphoma Myeloma Leuk | 2019 | https://conductscience.org/library/papers/30584023 | PubMed |
| 19 | 27994065 | Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial. | Neuro Oncol | 2017 | https://conductscience.org/library/papers/27994065 | PubMed |
| 20 | 30408153 | MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma. | Br J Haematol | 2019 | https://conductscience.org/library/papers/30408153 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42741313 | Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42741313 | PubMed |
| 42504027 | Survival Outcomes and Prognostic Factors in Patients With Primary Central Nervous System Low-Grade B-Cell Lymphoma: A Population-Based Cohort Study. | Cancer Med | 2026 | https://conductscience.org/library/papers/42504027 | PubMed |
| 42473159 | Case Report: Primary Central Nervous System Lymphoma With "Wine Glass" Sign Presenting as Somnolence and Fatigue. | Am J Case Rep | 2026 | https://conductscience.org/library/papers/42473159 | PubMed |
| 42453186 | Primary central nervous system lymphoma-current standards and recent developments. | Neurooncol Pract | 2026 | https://conductscience.org/library/papers/42453186 | PubMed |
| 42226306 | Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42226306 | PubMed |
| 41699536 | A case report: primary central nervous system lymphoma misdiagnosed as neuromyelitis optica. | BMC Neurol | 2026 | https://conductscience.org/library/papers/41699536 | PubMed |
| 41545969 | Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41545969 | PubMed |
| 41320285 | Primary large B-cell lymphoma of the central nervous system mimicking inflammatory myelitis at initial presentation. | J Clin Exp Hematop | 2025 | https://conductscience.org/library/papers/41320285 | PubMed |
| 41256314 | Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide. | Front Oncol | 2025 | https://conductscience.org/library/papers/41256314 | PubMed |
| 41226558 | Acalabrutinib May Offer a New Therapeutic Approach for Consolidation and Maintenance of Primary CNS Lymphoma with Expression of MYD88 and CD79B Gene Variants: A Case Report and Literature Review of Primary CNS Lymphoma in the BTKi Era. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226558 | PubMed |
| 40956465 | Lymphoproliferative Disorders Mimicking Rheumatologic Disease: A Clinical Reasoning Perspective. | Curr Allergy Asthma Rep | 2025 | https://conductscience.org/library/papers/40956465 | PubMed |
| 40941006 | The Landscape of Primary Central Nervous System Lymphoma (PCNSL): Clinicopathologic and Genomic Characteristics and Therapeutic Perspectives. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40941006 | PubMed |
| 40867004 | Management of primary central nervous system lymphoma and coexisting heart failure with reduced ejection fraction: a narrative review. | Cardiooncology | 2025 | https://conductscience.org/library/papers/40867004 | PubMed |
| 40855487 | Multiparametric MRI for differential diagnosis of primary central nervous system lymphoma and atypical glioblastoma: an analysis incorporating DWI, DCE-MRI, and contrast agent preload DSC-PWI. | BMC Med Imaging | 2025 | https://conductscience.org/library/papers/40855487 | PubMed |
| 40688584 | Morphological, immunophenotypic and neuroradiological characteristics of primitive B-large cell diffuse lymphoma of the central nervous system: A retrospective cohort analysis. | Oncol Lett | 2025 | https://conductscience.org/library/papers/40688584 | PubMed |
| 40421905 | Post-marketing surveillance of tirabrutinib in 189 patients with r/r primary central nervous system lymphoma. | Future Oncol | 2025 | https://conductscience.org/library/papers/40421905 | PubMed |
| 40088978 | Blood-brain barrier crossing biopolymer targeting c-Myc and anti-PD-1 activate primary brain lymphoma immunity: Artificial intelligence analysis. | J Control Release | 2025 | https://conductscience.org/library/papers/40088978 | PubMed |
| 39981762 | Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort study. | Ann Clin Transl Neurol | 2025 | https://conductscience.org/library/papers/39981762 | PubMed |
| 39834936 | Primary large B-cell lymphoma of the central nervous system misdiagnosed as autoimmune encephalitis: a case report. | Front Oncol | 2024 | https://conductscience.org/library/papers/39834936 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38112784
GET https://conductscience.org/api/papers/v1/38112784/references?page=2